Cargando…
Development of Novel Male Contraceptives
Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health condi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070810/ https://www.ncbi.nlm.nih.gov/pubmed/31618525 http://dx.doi.org/10.1111/cts.12708 |
_version_ | 1783506060613517312 |
---|---|
author | Amory, John K. |
author_facet | Amory, John K. |
author_sort | Amory, John K. |
collection | PubMed |
description | Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health conditions or side effects. Many men wish to take a more active role family planning, but currently have only two effective male contraceptive options, condoms and vasectomy. Therefore, work to develop novel male contraceptives analogous to popular female methods, such as daily pills or long‐acting shots and implants, is underway. This paper will briefly discuss the pros and cons of condoms and vasectomies, and then review the research into novel methods of male contraception. |
format | Online Article Text |
id | pubmed-7070810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70708102020-03-17 Development of Novel Male Contraceptives Amory, John K. Clin Transl Sci Reviews Unintended pregnancy is surprisingly common, accounting for 40–50% of pregnancies worldwide. Contraception is the most effective means of preventing unintended pregnancy. Seventy percent of all contraceptives are used by women; however, some women are unable to use contraceptives due to health conditions or side effects. Many men wish to take a more active role family planning, but currently have only two effective male contraceptive options, condoms and vasectomy. Therefore, work to develop novel male contraceptives analogous to popular female methods, such as daily pills or long‐acting shots and implants, is underway. This paper will briefly discuss the pros and cons of condoms and vasectomies, and then review the research into novel methods of male contraception. John Wiley and Sons Inc. 2019-11-14 2020-03 /pmc/articles/PMC7070810/ /pubmed/31618525 http://dx.doi.org/10.1111/cts.12708 Text en © 2019 The Author. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Reviews Amory, John K. Development of Novel Male Contraceptives |
title | Development of Novel Male Contraceptives |
title_full | Development of Novel Male Contraceptives |
title_fullStr | Development of Novel Male Contraceptives |
title_full_unstemmed | Development of Novel Male Contraceptives |
title_short | Development of Novel Male Contraceptives |
title_sort | development of novel male contraceptives |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070810/ https://www.ncbi.nlm.nih.gov/pubmed/31618525 http://dx.doi.org/10.1111/cts.12708 |
work_keys_str_mv | AT amoryjohnk developmentofnovelmalecontraceptives |